ACON Bios Investors, L.P. — Form D
ACON Bios Investors, L.P. of WASHINGTON, DC, a company, filed a Form D exempt-offering notice with the SEC on 2018-12-21. The offering totals $25.0M, of which $25.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2018-12-21
- Form: D
- Accession: 0001567619-18-008497
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $25.0M
- Amount sold: $25.0M
- Investors: 2
- Date of first sale: 2018-12-17
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-328782
Issuer
- Name: ACON Bios Investors, L.P.
- CIK: 0001761493
- Entity type: Limited Partnership
- Jurisdiction: CANADA (FEDERAL LEVEL)
- Incorporated: 2018
- Address: 1133 CONNECTICUT AVENUE, N.W., SUITE 700, WASHINGTON, DC, 20036
- Phone: 202-454-1100
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Teresa Y Bernstein | Executive Officer | Washington D.C., DC |
| Jose Knoell | Executive Officer | Washington, DC |
| KWAME Y LEWIS | Executive Officer | Washington, DC |
| N/A ACON Bios GenPar, L.L.C. | Promoter | Washington, DC |
More